Erivedge 150 mg (Vismodegib CAPSULE) 150 MG

Erivedge 150 mg capsules are a prescription medication used to treat certain types of cancer. This oral capsule contains the active ingredient Vismodegib and is manufactured by Hoffmann-La Roche Limited in Canada.

Strength

150 MG

Pack Size

Manufacturer / TM Owner

HOFFMANN-LA ROCHE LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Erivedge 150 mg capsules are primarily used in the treatment of basal cell carcinoma, a type of skin cancer. This medication works by targeting specific proteins involved in the growth and spread of cancer cells. Patients may wonder, 'What is Erivedge used for?' and the answer is that it is specifically indicated for advanced basal cell carcinoma that has spread or cannot be treated with surgery or radiation.

Side Effects

Common effects of Erivedge 150 mg capsules may include muscle spasms, hair loss, and changes in taste. Some users might experience fatigue or nausea. It is important to note that individual responses to the medication can vary, and not everyone will experience these effects.

Precautions & Warnings

Erivedge 150 mg capsules should be handled with care and stored as directed. It is important to follow the prescribing healthcare provider's instructions for use. Pregnant women should avoid handling this medication due to potential risks. Always consult a healthcare professional before starting any new medication.

Avoid Interactions

Erivedge 150 mg capsules may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy or safety of the medication.

References

Frequently Asked Questions

Erivedge is used to treat advanced basal cell carcinoma, a type of skin cancer, that has spread or cannot be treated with surgery or radiation.

Erivedge should be taken orally, exactly as prescribed by your healthcare provider. Follow the instructions on the label and consult your healthcare provider for specific guidance.

Common side effects may include muscle spasms, hair loss, changes in taste, fatigue, and nausea. Individual experiences may vary.

It is important to discuss alcohol consumption with your healthcare provider, as it may affect the efficacy or safety of Erivedge.

Erivedge is manufactured by Hoffmann-La Roche Limited in Canada.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.